Advanced Analytical Workflow Solutions for Monitoring Critical Quality Attributes of Monoclonal Antibodies
Article
Sponsored Content
Recombinant mAbs tend to be unstable and susceptible to modification/degradation.
These mAbs need to be identified/monitored for successful drug development.
New advanced LC–MS workflows have been developed to meet such needs.